Global Pharmaceutical Lipid-Based Excipients Market Size To Exceed USD 2.85 Billion By 2035 | CAGR of 4.53%

Global Pharmaceutical Lipid-Based Excipients Market Size To Exceed USD 2.85 Billion By 2035

According to a research report published by Spherical Insights & Consulting, the Global Pharmaceutical Lipid-Based Excipients Market Size is Expected To Grow from USD 1.75 Billion in 2024 to USD 2.85 Billion by 2035, at a CAGR of 4.53% during the forecast period 2025-2035.

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global Pharmaceutical Lipid-Based Excipients Market Size, Share, and COVID-19 Impact Analysis, By Excipient Type (Oils, Hydrogenated Vegetable Oils, GMCC (Glyceryl Monostearate), Hard Fats, and Others), By Product Applications (Oral Formulations, Parenteral, Topical Formulations, Ophthalmic Applications, and Others), By Industry Application (Pharmaceutical (OTC & Rx) and Nutraceutical (Dietary Supplements & Others)), By End-Use (Pharmaceutical Manufacturers, Contract Development & Manufacturing Organizations (CDMOs), and Other End Users), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035."Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/pharmaceutical-lipid-based-excipients-market  

The Pharmaceutical Lipid-Based Excipients Market Size is a sector of the pharmaceutical industry emphasizing lipid-based inactive ingredients (excipients) used to improve drug delivery. lipid-based excipients used in the pharmaceutical industry aid in enhancing the solubility, stability, and bioavailability of drugs, as well as controlling drug release in the body. The surging development of nanoparticles for a broad range of clinical applications is contributing to a significant surge in the market. Further, the ongoing development of lipid-based formulations is providing a growth opportunity in the pharmaceutical lipid-based excipients market. The pharmaceutical lipid based excipients market is primarily driven by emphasis on advanced drug delivery systems as well as implementation of patient-centric design of topical dermatological medicines. However, strict quality regulations, complexity in supply chain management, and increasing investment & development costs are challenging the market.  

The oils segment dominated the market with the largest share of about 40% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the excipient type, the pharmaceutical lipid-based excipients market size is divided into oils, hydrogenated vegetable oils, GMCC (glyceryl monostearate), hard fats, and others. Among these, the oils segment dominated the market with the largest share of about 40% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Oils are used in a wide range of pharmaceutical products, from parenteral nutrition to soft gel formulations with poor aqueous solubility and poor oral bioavailability. The use of injectable-grade oil in the pharmaceutical industry in depot formulations is contributing to driving the market growth.

The topical formulations segment accounted for the largest share of about 51% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the product applications, the pharmaceutical lipid-based excipients market size is divided into oral formulations, parenteral, topical formulations, ophthalmic applications, and others. Among these, the topical formulations segment accounted for the largest share of about 51% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. An increasing demand for patient-friendly topical treatments in dermatology and mucosal applications is propelling market growth. Topically applied drug loaded nanoparticles are intended for local effect to prevent drug administration and lower the amount of dose required to reach a therapeutic level.

The pharmaceutical (OTC & Rx) segment accounted for the largest share of about 61% in 2024 and is expected to grow at a significant CAGR during the projected period.

Based on the industry application, the pharmaceutical lipid-based excipients market size is divided into pharmaceutical (OTC & Rx) and nutraceutical (dietary supplements & others). Among these, the pharmaceutical (OTC & Rx) segment accounted for the largest share of about 61% in 2024 and is expected to grow at a significant CAGR during the projected period. Lipids are used for designing formulations for enhancing the aqueous solubility and drug bioavailability, especially for poorly aqueous soluble drugs. Strategic collaborations among drug developers and lipid excipient manufacturers contribute to propelling the segmental market growth.

The pharmaceutical manufacturers segment accounted for a major market share of about 64% in 2024 and is expected to grow at a significant CAGR during the projected period.

Based on the end-use, the pharmaceutical lipid-based excipients market size is divided into pharmaceutical manufacturers, contract development & manufacturing organizations (CDMOs), and other end users. Among these, the pharmaceutical manufacturers segment accounted for a major market share of about 64% in 2024 and is expected to grow at a significant CAGR during the projected period. For instance, ABITEC Corporation is a global leader in the development and manufacture of highly functional lipid-based excipients for the pharmaceutical industry. Surging need for new drug formulations along with advanced delivery systems is propelling the market.

North America is expected to hold the majority share of the global pharmaceutical lipid-based excipients market during the forecast period.

North America is expected to hold the majority share of over 38% in the global pharmaceutical lipid-based excipients market size during the forecast period. The U.S. is leading the North America pharmaceutical lipid-based excipients market during the forecast period, due to the increasing chronic disease prevalence and personalized medicine approach. The market for pharmaceutical lipid-based excipients has been driven by the region's advanced pharmaceutical manufacturing infrastructure, strong R&D base, and leading global drug makers. Further, an increasing trend towards more personalized therapies, which is influencing the need for tailored excipient solutions, is contributing to promoting the market.

Asia Pacific is anticipated to grow at the fastest pace of CAGR 5.6% in the global pharmaceutical lipid-based excipients market size during the forecast period. China is dominating the Asia Pacific pharmaceutical lipid-based excipients market, driven by the increasing pharmaceutical manufacturing, investment in drug delivery technologies, and cost-effective production. The Asia Pacific area has a thriving market for pharmaceutical lipid-based excipients due to its increasing geriatric population and prevalence of chronic diseases like diabetes and cancer, which is responsible for driving the demand for advanced drug delivery systems with high-quality excipients.

Major vendors in the global pharmaceutical lipid-based excipients market size  are ABITEC Corporation, BASF, Gattefossé, CordenPharma, Lipoid, IOI Oleo GmbH, Croda International, Evonik Industries, Ashland, Merck KGaA, Alsiano, Biopharma PEG Scientific, CD Formulation, CLARIANT, CREMER OLEO, Kao Corporation, and Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development 

• In September 2025, Gattefosse is strengthening its global footprint with the grand opening of its first production facility in North America. The French supplier of ingredients and formulation solutions for the cosmetics and pharmaceutical industries has inaugurated its first North American manufacturing facility in Lufkin, Texas. This new site complements the group’s existing operations in France and Singapore.

• In September 2025, Evonik, a global specialty chemicals company, and Ethris, a clinical stage biotechnology company pioneering next generation RNA therapeutics and vaccines, entered into a strategic collaboration to develop and market a novel lipid nanoparticle (LNP) platform for nucleic acid delivery.

• In January 2025, Evonik partnered with ST Pharm, a CDMO based in South Korea that manufactures active ingredients for gene therapy, to expand its RNA and nucleic acid therapeutic services. Through the partnership, Evonik would be able to provide customized nucleic acids from ST Pharm alongside its portfolio of lipid and lipid nanoparticle (LNP) drug product development services.

• In November 2024, Gattefosse, a provider of excipients and technical support for pharmaceuticals, veterinary drugs, and dietary supplements, opened new offices and a state-of-the-art Technical Center of Excellence in Mumbai to support the growing market in India.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the pharmaceutical lipid-based excipients market based on the below-mentioned segments:

Global Pharmaceutical Lipid-Based Excipients Market, By Excipient Type

• Oils
• Hydrogenated Vegetable Oils
• GMCC (Glyceryl Monostearate)
• Hard Fats
• Others

Global Pharmaceutical Lipid-Based Excipients Market, By Product Applications

• Oral Formulations
• Parenteral
• Topical Formulations
• Ophthalmic Applications
• Others

Global Pharmaceutical Lipid-Based Excipients Market, By Industry Application

• Pharmaceutical (OTC & Rx)
• Nutraceutical (Dietary Supplements & Others)

Global Pharmaceutical Lipid-Based Excipients Market, By End-Use

• Pharmaceutical Manufacturers
• Contract Development & Manufacturing Organizations (CDMOs)
• Other End Users

 Global Pharmaceutical Lipid-Based Excipients Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter